See what’s trending right now

6 hours ago

Starmer's new NHS plan promises major reforms to tackle waiting times and rewire healthcare, sparking debate on its potential impact.

See related stories

Home Health

The big business behind weight-loss drugs: Global market to hit $150 billion by 2035

France 24Thursday, July 3, 2025 at 3:43:01 PM

The weight-loss drug market is exploding, with new GLP-1 medications like Ozempic and Wegovy driving a pharmaceutical gold rush. These drugs are hailed as revolutionary for obesity treatment, but they’re expensive and come with side effects affecting up to 70% of users. A health economist breaks down who stands to profit most from this booming industry, projected to hit $150 billion by 2035.

Editor’s Note: This isn’t just about shedding pounds—it’s a massive shift in healthcare and big pharma’s bottom line. While these drugs offer hope for millions, their high cost and side effects raise tough questions about accessibility and long-term impact. Whether you’re a patient, investor, or just watching healthcare trends, this story highlights the messy intersection of health, profit, and innovation.

— Curated via WP Now’s

Pharmaceuticals

Read Original

Was this article worth reading? Share it

Latest from Health

The New York Times4 hours ago

Drugmakers Notch a $5 Billion Win in Republicans’ Policy Bill

negativeHealth

Big pharmaceutical companies just scored a major victory in a Republican-backed policy bill—worth around $5 billion—by shielding more drugs from Medicare price negotiations. This move is expected to gut billions in potential savings for the government, meaning taxpayers and Medicare beneficiaries could end up footing a higher bill.

Editor’s Note: This isn’t just inside baseball—it’s a big deal for anyone who relies on Medicare or cares about drug prices. The government’s ability to negotiate lower prices for expensive medications just got weaker, which could keep costs high for patients and strain federal budgets. It’s a win for drugmakers but likely a loss for everyone else.

Read full article

via The New York Times

NBC News4 hours ago

Dozens of beaches across the U.S. close before July Fourth weekend due to fecal bacteria

negativeHealth

Right before the big July Fourth holiday, health officials have shut down or warned visitors away from dozens of beaches nationwide—turns out, there’s way too much nasty bacteria (yes, including poop-related germs) in the water. Not exactly the beach day everyone was hoping for.

Editor’s Note: This is a major buzzkill for summer plans, but it’s also a serious health issue. Contaminated water can cause nasty infections, and with crowds flocking to beaches for the holiday, these closures are a big deal. It highlights ongoing problems like aging sewage systems and runoff pollution—stuff that needs fixing before more summers get spoiled.

Read full article

via NBC News

BBC News6 hours ago

Seven ways Starmer's plan could change the NHS

neutralHealth

The BBC breaks down Labour leader Keir Starmer’s proposed 10-year plan for the NHS, outlining seven key ways it could reshape healthcare—from staffing and wait times to funding and tech upgrades. It’s a mix of ambitious reforms and cautious pledges, with the details hinting at both opportunities and challenges ahead.

Editor’s Note: The NHS is a political lightning rod, and Starmer’s plan could mean real changes for patients and workers—whether it’s shorter waits or shifts in how services are run. But with big promises come big questions: Can it actually work? This isn’t just bureaucratic tweaking; it’s about the future of a system millions rely on.

Read full article

via BBC News

Dow Jones - Health7 hours ago

Health Care Roundup: Market Talk

neutralHealth

This piece is part of a regular series digging into the latest chatter and trends in the health care sector, with a spotlight on big players like Samsung Biologics and emerging biotech firms in China. Think of it as a quick but insightful snapshot of where money is moving, who’s making waves, and what’s bubbling up in labs and boardrooms.

Editor’s Note: If you’re tracking the business side of health care—whether you’re an investor, industry insider, or just curious about where breakthroughs might come from next—this kind of update helps connect the dots between corporate moves and real-world medical advances. It’s not just about stock prices; it’s a window into who’s betting big on the future of medicine.

Read full article

via Dow Jones - Health

France 247 hours ago

The big business behind weight-loss drugs: Global market to hit $150 billion by 2035

neutralHealth

Read full article

via France 24